Ono Pharmaceutical Co Stock Investor Sentiment

OPHLF Stock  USD 9.60  1.07  10.03%   
Roughly 61% of Ono Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Ono Pharmaceutical Co pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Ono Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Ono Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Ono Pharmaceutical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ono daily returns and investor perception about the current price of Ono Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
BMS accuses AZ of Opdivo patent infringement in new lawsuit - FiercePharma
Google News at Macroaxis
over a year ago at news.google.com         
Europe Underactive Bladder Market Size, Share, Industry, Forecast to 2029 - openPR
Google News at Macroaxis
over a year ago at news.google.com         
Non-Steroidal Anti-inflammatory Drugs Global Market Report 2023 - Yahoo Finance UK
Google News at Macroaxis
over a year ago at news.google.com         
Global Underactive Bladder Market Size, Share, Industry, Forecast to 2029 - openPR
Google News at Macroaxis
over a year ago at news.google.com         
ONO PHARMA USA Announces 2023 Golden Ticket Competition in Partnership with LabCentral and MBC BioLa...
Google News at Macroaxis
over a year ago at news.google.com         
PARP Inhibitor Market Latest Report Performance Matrix, Key ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Memantine Market Factors Benefitting Emergence of New Entrants ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
PARP Inhibitor Market With Focus On Growth Analysis, Production ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Active Pharmaceutical Ingredients Market Size Share to Surpass ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
FDA dubs Abbotts FreeStyle Libre battery issues a Class I recall ... - FierceBiotech
Google News at Macroaxis
over a year ago at news.google.com         
Lung Cancer Therapeutics Market Estimated to Reach USD 19.5 ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
FDA Accepts Pfizers Supplemental New Drug Applications for ... - Pfizer
Google News at Macroaxis
over a year ago at news.google.com         
Acute Heart Failure Therapeutics Market Expected to Expand ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
PARP Inhibitor Market Inclination of Leading Players towards RD ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Equillium Reports Fourth Quarter and Full Year 2022 Financial ... - Tullahoma News and Guardian
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ono Pharmaceutical that are available to investors today. That information is available publicly through Ono media outlets and privately through word of mouth or via Ono internal channels. However, regardless of the origin, that massive amount of Ono data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ono Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ono Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ono Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ono Pharmaceutical alpha.

Ono Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ono Pink Sheet analysis

When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.